Publication | Closed Access

Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma

UrologyGenitourinary CancerImmunologyCancer GenomicsImmune Checkpoint InhibitorTyrosine Kinase InhibitionMedicineTumor MicroenvironmentGenomic ProfilingImmune Checkpoint Inhibition